Murali Yallapu to Macrophages
This is a "connection" page, showing publications Murali Yallapu has written about Macrophages.
Connection Strength
0.203
-
Gong Y, Chowdhury P, Nagesh PKB, Rahman MA, Zhi K, Yallapu MM, Kumar S. Novel elvitegravir nanoformulation for drug delivery across the blood-brain barrier to achieve HIV-1 suppression in the CNS macrophages. Sci Rep. 2020 03 02; 10(1):3835.
Score: 0.120
-
Kotnala S, Dhasmana A, Dhasmana S, Haque S, Yallapu MM, Tripathi MK, Jaggi M, Chauhan SC. A Systems Biology Approach Unveils a Critical Role of DPP4 in Upper Gastrointestinal Cancer Patient Outcomes. J Environ Pathol Toxicol Oncol. 2024; 43(2):43-55.
Score: 0.039
-
Gong Y, Zhi K, Nagesh PKB, Sinha N, Chowdhury P, Chen H, Gorantla S, Yallapu MM, Kumar S. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia. Viruses. 2020 05 20; 12(5).
Score: 0.030
-
Reddy MK, Vasir JK, Sahoo SK, Jain TK, Yallapu MM, Labhasetwar V. Inhibition of apoptosis through localized delivery of rapamycin-loaded nanoparticles prevented neointimal hyperplasia and reendothelialized injured artery. Circ Cardiovasc Interv. 2008 Dec; 1(3):209-16.
Score: 0.014